UNSPSC 85613544: Dilation of accessory pancreatic duct with intraluminal device, via natural or artificial opening endoscopic

This classification denotes the group of activities that yields a surgical intervention or procedure to dilation of accessory pancreatic duct with intraluminal device, via natural or artificial opening endoscopic. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0F7F8DZ

UNSPSC 85613544 Dilation of accessory pancreatic duct with intraluminal device, via natural or artificial opening endoscopic is a Commodity code that shows no recent state and local procurement activity aligned with its clinical medical procedure scope. The recent opportunities tagged under this code—independent medical evaluations for disability determinations, surgical procedure carve-out benefits, occupational medical surveillance, youth detention healthcare services, pharmacy benefit management, and temporary health professional staffing—represent administrative health services, benefit program management, and general staffing, not specialized endoscopic interventions on pancreatic ductal systems. The mismatch suggests either a data-tagging error in the source records or a fundamental misalignment between the code's clinical specificity and how state and local bodies are currently classifying their health-services procurement.

State and local procurement under this code appears dormant or absent from recent RFP, RFQ, IFB, and ITB activity. When a clinical procedure code does not surface in active state and local opportunities, it typically signals either that the procedure is procured at the federal level (VA, DOD, CMS contracting), purchased through private healthcare networks rather than public procurement channels, or classified under higher-level health-services families by issuing bodies unfamiliar with granular UNSPSC medical procedure taxonomy. Monitor this code for future activity, but currently no pursuit opportunity is present in the state and local market.